Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Gemcitabine/Docetaxel and Doxorubicin for Uterine Leiomyosarcoma
NCT00282087Phase 2Completed
- Sponsor
- Sarcoma Alliance for Research through Collaboration
- Start
- Jan 2006
- Primary completion
- Jan 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, docetaxel, doxorubicin in uterine leiomyosarcoma (uLMS), sponsored by Sarcoma Alliance for Research through Collaboration. Started Jan 2006; status: completed.
02
Drugs
gemcitabinedocetaxeldoxorubicin
03
Conditions
uterine leiomyosarcoma (uLMS)
Beyond the preview
Go deeper on NCT00282087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00282087.